Characterization of PSA at death in patients with metastatic castration-resistant prostate cancer.

被引：1
|
作者：
Bikkasani, Krishna
Qin, Qian
Lin, Justin
Galsky, Matt D.
Liaw, Bobby Chi-Hung
Oh, William K.
Tsao, Che-Kai
机构：
[1] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, New York, NY 10029 USA
[2] CUNY, Sch Med, New York, NY 10031 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.184
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
184
引用
收藏
页数：2
相关论文
共 50 条
  • [41] PSA progression compared to radiographic or clinical progression in metastatic castration-resistant prostate cancer patients treated with enzalutamide
    Gandhy, Shruti U.
    Karzai, Fatima
    Marte, Jennifer L.
    Bilusic, Marijo
    McMahon, Sheri
    Strauss, Julius
    Couvillon, Anna
    Williams, Monique
    Hankin, Amy
    Steinberg, Seth M.
    Figg, William Douglas
    Arlen, Philip M.
    Dahut, William L.
    Gulley, James L.
    Madan, Ravi Amrit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [42] Low hemoglobin and PSA kinetics are prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients
    Hakozaki, Yuji
    Yamada, Yuta
    Takeshima, Yuta
    Taguchi, Satoru
    Kawai, Taketo
    Nakamura, Masaki
    Iwaki, Takuya
    Teshima, Taro
    Kinoshita, Yoshitaka
    Akiyama, Yoshiyuki
    Sato, Yusuke
    Yamada, Daisuke
    Suzuki, Motofumi
    Kume, Haruki
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [43] Low abiraterone plasma concentration fails to induce PSA regression in metastatic castration-resistant prostate cancer patients
    Carton, E.
    Noe, G.
    Huillard, O.
    Golmard, J. L.
    Giroux, J.
    Cessot, A.
    Peyromaure, M.
    Zerbib, M.
    Narjoz, C.
    Thomas, A.
    Vidal, M.
    Goldwasser, F.
    Blanchet, B.
    Alexandre, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S491 - S491
  • [44] Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Danila, D. C.
    Leversha, M. A.
    Gonzalez-Espinoza, R.
    Anand, A.
    Gu, B.
    Gignac, G. A.
    Larson, S.
    Heller, G.
    Fleisher, M.
    Scher, H. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
    Anido-Herranz, U.
    Fernandez-Nunez, N.
    Afonso-Afonso, J.
    Santome-Couto, L.
    Medina-Colmenero, A.
    Fernandez-Calvo, O.
    Lazaro-Quintela, M.
    Vazquez, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (03): : 249 - 258
  • [46] Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
    U. Anido-Herranz
    N. Fernández-Núñez
    J. Afonso-Afonso
    L. Santomé-Couto
    A. Medina-Colmenero
    O. Fernández-Calvo
    M. Lázaro-Quintela
    S. Vázquez
    Clinical and Translational Oncology, 2019, 21 : 249 - 258
  • [47] Lenalidomide and cyclophosphamide immunoregulation in patients with metastatic, castration-resistant prostate cancer
    Wang, J.
    McGuire, T. R.
    Britton, H. C.
    Schwarz, J. K.
    Loberiza, F. R., Jr.
    Meza, J. L.
    Talmadge, J. E.
    CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (02) : 111 - 124
  • [48] Lenalidomide and cyclophosphamide immunoregulation in patients with metastatic, castration-resistant prostate cancer
    J. Wang
    T. R. McGuire
    H. C. Britton
    J. K. Schwarz
    F. R. Loberiza
    J. L. Meza
    J. E. Talmadge
    Clinical & Experimental Metastasis, 2015, 32 : 111 - 124
  • [49] Predictors of overall survival in patients with metastatic castration-resistant prostate cancer
    Markova, A. S.
    Polikarpova, S. B.
    Kamolov, B. Sh.
    Gridneva, Ya. V.
    Kalinin, S. A.
    Peters, M. V.
    Matveev, V. B.
    ONKOUROLOGIYA, 2015, 11 (02): : 77 - 84
  • [50] New treatment options for patients with metastatic castration-resistant prostate cancer
    Higano, Celestia S.
    CANCER TREATMENT REVIEWS, 2012, 38 (05) : 340 - 345
12345